Intellia Therapeutics Inc (NTLA)
Stock-Based Compensation
$18.08M
Quarterly · Period ending: · USD
NTLA Stock-Based Compensation
Latest reported$18.08Mperiod ending
Latest reported$18.08Mperiod ending
NTLA Quarterly Stock-Based Comp ($0.00 → $18.08M)
Quarterly stock-based compensation
High-resolution chart · PNG
NTLA stock-based compensation history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 18,075,000 | |
| 13,479,000 | |
| 90,793,000 | |
| 19,604,000 | |
| 22,036,000 | |
| 21,840,000 | |
| 39,617,000 | |
| 39,619,000 | |
| 40,861,000 | |
| 34,176,000 | |
| 35,043,000 | |
| 35,352,000 | |
| 36,400,000 | |
| 27,255,000 | |
| 24,626,000 | |
| 25,215,000 | |
| 23,068,000 | |
| 18,491,000 | |
| 14,561,000 | |
| 15,410,000 | |
| 10,614,000 | |
| 6,424,000 | |
| 5,582,000 | |
| 5,400,000 | |
| 4,764,000 | |
| 4,157,000 | |
| 3,016,000 | |
| 3,079,000 | |
| 4,404,000 | |
| 4,592,000 | |
| 3,582,000 | |
| 4,456,000 | |
| 4,901,000 | |
| 4,107,000 | |
| 6,596,000 | |
| 3,247,000 | |
| 2,849,000 | |
| 2,630,000 | |
| 2,015,000 | |
| 2,055,000 | |
| 1,833,000 | |
| 812,000 | |
| 463,000 | |
| 579,000 | |
| 151,000 | |
| 115,000 | |
| 270,000 | |
| 0 |